Skip to content

AtriCure ATRC Financing Cash Flow

Financing Cash Flow at other companies

Abbott logo
AbbottABT
$17.31B+942%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$530M-94.9%
Boston Scientific logo
Boston ScientificBSX
-$260M-212%
Medtronic logo
MedtronicMDT
-$888M+33.9%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$2.21M-85.1%
ITG
Integer HoldingsITGR
$3.83M-97.5%

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's financing cash flow?
AtriCure (ATRC) reported financing cash flow of -$13.26M in Q1 2026.
How has AtriCure's financing cash flow changed year-over-year?
AtriCure's financing cash flow decreased by 28.4% year-over-year, from -$10.33M to -$13.26M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.